Ross is a biomedical engineer with a personal passion for developing neuromodulation therapies for hearing and auditory system disorders. He founded Neuromod in 2010 to develop non-invasive neuromodulation treatments for chronic neurological disorders.

Manus is a chemist who began his career in drug development before moving into business development and venture capital investment, establishing Fountain Healthcare Partners in the 2000’s to invest in groundbreaking technologies in the life science sector.

Susan has more than 30 years’ experience in the hearing industry, having worked as both a business executive and a practicing clinical audiologist. She served as president of the Academy of Doctors of Audiology (ADA) from 1992-1994. She has also held many leadership roles at companies such as GN Resound, InSound Medical and Phonak US. More recently, Susan started a consulting business focused on start-up innovation in hearing and healthcare.

Alessio is Co-Founder and General Partner of Panakès Partners, a Venture Capital fund dedicated to life sciences and headquartered in Milan, Italy with more than €250 million under management. Alessio has significant VC experience earned at Sofinnova Partners, one of Europe's largest VCs, where he progressed from Analyst to Partner positions with European and American exposure.

He began his career in 1997 as a researcher at LETI, one of the most important European labs in the research field, before joining the central R&D group of STMicroelectronics. He graduated from Politecnico di Milano, with a degree in chemical engineering, specialising in the chemistry and physics of solid materials, and with an MBA from the Ecole Supérieure de Commerce de Paris (ESCP-EAP).

Alessio is a Kauffman Fellow and sits on the board of Alesi Surgical ltd, MMI spa and Neuromod Devices ltd. Alessio is also General Secretary of the Italian Tech Alliance.